06/03/2026
Victor Sung, M.D., was recently featured in NeurologyLive, where he shared new insights into Huntington disease research.
Three-year data on AMT-130 show promising signs of slowing disease progression, a meaningful step forward in a space where treatment options remain limited.
Hear more from Dr. Sung:
The professor of neurology and director of the Division of Movement Disorders at the University of Alabama at Birmingham discussed 3-year data on AMT-130 and its potential as a disease-modifying gene therapy for Huntington disease. [WATCH TIME: 3 minutes]